Catalyst Wire Dossier Catalyst Wire Dossier

Ibandronic acid

ibandronic acid · Chugai Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ibandronic acid, covering 2012-08-02 to 2012-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis [Phase 3]

See pricing